Hepatitis B virus X protein-mediated non-coding RNA aberrations in the development of human hepatocellular carcinoma

被引:0
作者
Bei Zhang
Siqi Han
Bing Feng
Xiaoyuan Chu
Longbang Chen
Rui Wang
机构
[1] Jinling Hospital,Department of Medical Oncology
[2] School of Medicine,undefined
[3] Nanjing Medical University,undefined
来源
Experimental & Molecular Medicine | 2017年 / 49卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Hepatitis B virus (HBV) has an important role in the development of human hepatocellular carcinoma (HCC). Accumulated evidence has shown that HBV-encoded X protein (HBx) can induce both genetic alterations in tumor suppressor genes and oncogenes, as well as epigenetic aberrations in HCC pathogens. Non-coding RNAs (ncRNAs) mainly include microRNAs and long non-coding RNAs (lncRNAs). Although ncRNAs cannot code proteins, growing evidence has shown that they have various important biological functions in cell proliferation, cell cycle control, anti-apoptosis, epithelial–mesenchymal transition, tumor invasion and metastasis. This review summarizes the current knowledge regarding the mechanisms and emerging roles of ncRNAs in the pathogenesis of HBV-related HCC. Accumulated data have shown that ncRNAs regulated by HBx have a crucial role in HBV-associated hepatocarcinogenesis. The findings of these studies will contribute to more clinical applications of HBV-related ncRNAs as potential diagnostic markers or as molecular therapeutic targets to prevent and treat HBV-related HCC.
引用
收藏
页码:e293 / e293
相关论文
共 619 条
  • [1] Siegel R(2014)Cancer statistics CA Cancer J Clin 64 9-29
  • [2] Ma J(2010)Epidemiology of chronic hepatitis B virus infection, hepatocellular carcinoma, and hepatitis B virus-induced hepatocellular carcinoma Pathol Biol 58 273-277
  • [3] Zou Z(2001)Hepatitis B virus and hepatocellular carcinoma Int J Exp Pathol 82 77-100
  • [4] Jemal A(2014)Hepatitis B virus X protein accelerates the development of hepatoma Cancer Biol Med 11 182-190
  • [5] Kew MC(2003)Alterations of RB1, p53 and Wnt pathways in hepatocellular carcinomas associated with hepatitis C, hepatitis B and alcoholic liver cirrhosis Int J Cancer 106 334-341
  • [6] Arbuthnot P(2007)Molecular pathways and related target therapies in liver carcinoma Curr Pharm Des 13 3279-3287
  • [7] Kew M(2011)Hepatitis B virus x protein in the pathogenesis of hepatitis B virus-induced hepatocellular carcinoma J Gastroenterol Hepatol 26 144-152
  • [8] Zhang XD(2006)Roles of the RAF/MEK/ERK and PI3K/PTEN/AKT pathways in malignant transformation and drug resistance Adv Enzyme Regul 46 249-279
  • [9] Wang Y(2001)X protein of hepatitis B virus modulates cytokine and growth factor related signal transduction pathways during the course of viral infections and hepatocarcinogenesis Cytokine Growth Factor Rev 12 189-205
  • [10] Ye LH(2007)TP53 mutations and hepatocellular carcinoma: insights into the etiology and pathogenesis of liver cancer Oncogene 26 2166-2176